Latest News
Instem Expands In Silico Toxicology Service To Meet Growing Demand
Newly Added Services to Support Latest Regulatory Guidance and Growing Demand for Alternative Testing Methods
PHILADELPHIA, PA – (BUSINESS WIRE) – November 22, 2021 - Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that it has further enhanced its Predict™ In Silico Toxicology service portfolio by adding four new services.
Instem Acquires PDS Life Sciences to Help Clients Bring Life Enhancing Products to Market Faster and More Efficiently
September 1, 2021 - Acquisition of PDS Life Sciences Consolidates Non-Clinical Market; Further Extends Instem’s Leadership in Study Management and Regulatory SEND Submission Support
Instem to Release Next Edition of its Leading Computational Toxicology Software Suite
July 29, 2021 - Powerful New In Silico Models and First-to-Market Software Capabilities to Deliver Further Efficiencies and Increased Regulatory Compliance
Instem Acquires Market Leader d-wise to Further Accelerate Life Science Development
March 22, 2021 - Instem’s Acquisition of Leading Clinical Trial Technology and Consulting Provider d-wise Represents Substantial Advancement of its Mission
Instem Announces Acquisition of The Edge; Extends Reach within Discovery R&D
March 1, 2021 - Instem’s Acquisition of Discovery Technology Solutions Provider, The Edge, Represents Another Advancement of its Mission in the Life Sciences
Events
38th Annual Meeting of the Japanese Society of Toxicologic Pathology (STP)
January 27 - 28, 2022
Kobe International Conference Center, Hyogo, Japan
SOT 61st Annual Meeting
March 27 - 31, 2022
San Diego Convention Center, San Diego, Booths #1625 & #1729
Presentation
Assessment of whether acute toxicity in silico models are fit-for-purpose for classification and labelling
Wednesday, March 30